Tackling Antimicrobial Resistance Together: A Conversation with Dr. Beverley Isherwood
An interview with Dr Beverley Isherwood.
Stay updated with breaking news from Discovery Catapult. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
An interview with Dr Beverley Isherwood.
Innovate UK, LifeArc, and Medicines Discovery Catapult (MDC) have joined forces to create PACE (Pathways to Antimicrobial Clinical Efficacy), a £30 million initiative supporting early-stage innovation against antimicrobial resistance (AMR) to save lives. PACE has today (19 October 2023) announced its first funding call with up to £10 million available to support innovators developing new antimicrobials.
The UK's largest public-private initiative targeting early-stage antimicrobial drug and diagnostic discovery has been introduced by Innovate UK, LifeArc and Medicines Discovery Catapult (MDC). Click to read more...
/PRNewswire/ -- Alchemab Therapeutics, a biotechnology company unlocking new therapies from within the immune system, today announced that it has been awarded...
Advanced light microscopy is a powerful tool to reveal mechanisms of action and boost translation of complex medicines into the clinic